Previous studies suggest that ropivacaine causes the least neurotoxicity among local anaesthetics. Most data derive from a single injection of ropivacaine into the subarachnoid space. The histological changes and behavioural effects of repeated intrathecal administration have yet to be studied. We examined the possible neurotoxicity of multiple doses of intrathecal ropivacaine in rats.
Local anaesthetics have been used in the subarachnoid space for safe anaesthesia for more than 100 years. Previous studies suggest that ropivacaine causes the least neurotoxicity among local anaesthetics 1, 2 . Nevertheless, a relative high incidence of transient neurological symptoms and, rarely, cauda equina syndrome has been reported after uneventful spinal anaesthesia 3, 4 . In large retrospective surveys of 4000 to 10,000 patients, the incidence of persistent neuropathy after subarachnoid anaesthesia varies from 0.01 and 0.7% 5 . The exact mechanism of these syndromes remains unknown but some authors suggest that the neurotoxicity of intrathecal local anaesthetics might contribute. Different local anaesthetics exhibit variable propensities to induce neuronal injury. For example, Yamashita et al suggested that the extent of vacuolation of the dorsal funiculus was in the order of lignocaine=tetracaine >bupivacaine >ropivacaine 2 . Radwan et al suggested that mepivacaine was safer than lignocaine, bupivacaine and ropivacaine for primary cultured chicken neurons 6 . Sakura et al suggested that bupivacaine was less neurotoxic than lignocaine when administered intrathecally at equipotent concentrations in a rat model 7 . Thus, it has been difficult to reconcile all reported data to evaluate the safety profile of neuraxial administration of local anaesthetics, and the precise mechanism of neurotoxicity has been difficult to define. It is clear that further studies are needed to extend knowledge.
Ropivacaine was developed after evidence of bupivacaine-related severe systemic toxicity. For neuraxial anaesthesia, the major advantage of intrathecal ropivacaine is faster motor recovery compared to bupivacaine 8 and spinal anaesthesia with ropivacaine is being used increasingly 9, 10 . It has Z. Zhong, g. Qulian et al Anaesthesia and Intensive Care, Vol. 37, No. 6, November 2009 been reported that intrathecal ropivacaine might be neurotoxic [11] [12] [13] , so further study of ropivacaine neurotoxicity is warranted.
Continuous spinal anaesthesia (CSA) is an effective, reliable and safe technique for producing and maintaining spinal anaesthesia with small doses of local anaesthetics 14 . Many studies have shown that cauda equina syndrome is associated with CSA 4, 15 . CSA with ropivacaine has the potential to be used for postoperative analgesia, but potential neurotoxicity in the context of continuous infusion is unknown. Previous studies demonstrate the possibility of neurotoxicity from all long-acting local anaesthetics after excessive doses or a prolonged duration of exposure. Hyperbaricity may also be a factor when small-gauge (micro-) spinal catheters are used.
Previously, we reported that CSA with 1.0% ropivacaine for six hours showed some ultrastructural changes in the spinal cord and nerve roots in a rat model 16 . In this study, we investigated the possible neurotoxicity of ropivacaine in the context of CSA (administration over 48 hours). To further study the mechanism of neurotoxicity of ropivacaine, we hypothesised that apoptosis might play an important role in neuronal injury 17 .
MATERIALS AND METHoDS
The study was approved by the Ethics Committee for Animal Research of XiangYa Hospital in Central South University, P.R. China. Sprague-Dawley male rats (n=35, body weight 250 to 320 g) were used for the experiment. The rats were housed five per cage in the animal facility for one week before the experiment with a 12:12 hour light-dark cycle. Food and water were available at all times.
Surgical procedure for intrathecal catheterisation
The rats were anaesthetised with 10% chloral hydrate (intraperitoneal injection at 0.3 to 0.35 ml/ 100 g) and the subarachnoid space was cannulated with a polyurethane microspinal catheter (ID 0.12 mm, oD 0.35 mm) through the atlanto-occipital membrane with the modified method of Yaksh and Rudy 18 . The tip of the catheter was advanced 8 cm caudally to the L3 level. The other end of the catheter was fixed in the subcutaneous tissue to avoid dislocation.
The rats were observed for five days after intrathecal catheterisation. Rats that showed symptoms of traumatic nerve injury during catheterisation were excluded from further experiments.
Intrathecal administration of drugs
The 30 remaining rats were randomly divided into five groups (5×6). Rats received 0.12 ml/kg body weight of 0.25%, 0.5%, 0.75% or 1.0% ropivacaine in saline (AstraZeneca, Sweden) for 32 injections at 90 minute intervals for a duration of 48 hours. The same amount of saline was administered by the same method in the control group. Each solution was prepared aseptically and fresh on the morning of the day of the injection. The pH and osmolarity of each solution were measured by a refractometer (FL3-WY1A, Japan). The volume of each injection was 0.12 ml/kg body weight and the catheter was then flushed with 10 µl of saline to account for the deadspace of the catheter. At each injection, the solution was administered over 15 seconds. After injection, the catheter was capped with a pin.
Neurological function tests
A paw stimulation test was performed by an investigator who was blinded to the solution administered to each animal. Hind-limb withdrawal latencies to radiant heat (type 37370 UGo BASILE, Italy) and mechanical stimulation (type 2390 IITC, USA) were measured before injection (pre-latency, as baseline) and 1.5 hours after the last injection (post-latency). Measurements were repeated three times in each rat on both of the left and right paws. The data were expressed as the percentage of maximum possible effect (%MPE):
A cut-off time of 20 seconds and a cut-off pressure of 400 g were used to prevent thermal and mechanical injury. The effect of the drug on sensory function was evaluated by comparing the %MPE of the drug.
Motor function of lower limbs was assessed. The grading of the motor block was: 0=no block, normal ambulation, 1=partially blocked and 2=completely blocked. The normal baseline score was 0 and the score with bilateral complete block was 2+2=4. Motor function tests were performed every 10 minutes until the rats had totally recovered and were able to ambulate 7, 19 .
Perfusion fixation and tissue preparation
After the neurological function tests were finished, the animals under terminal anaesthesia were perfused transcardially with a fixative solution (saline 500 ml, followed by 4% paraformaldehyde 500 ml). Perfusion fixation takes advantage of the rat's circulatory system to deliver the fixative solution evenly throughout the body tissue, with optimal penetration of the central nervous system for histological and immunohistochemical examination. After fixation, the lumbar spinal cords with posterior roots were removed en bloc and each was dissected into three gross samples (A, B and C): the transverse section with lumbar spinal cord of L3 (sample A) for light microscopic examination and TUNEL staining (see TUNEL staining for apoptosis below), the posterior corner section of L3 (sample B), and the posterior roots section of L3 (sample C) for electron microscopic examination. Sample A was stored in 4% paraformaldehyde, while samples B and C were immersed in 2.5% glutaraldehyde phosphate buffer.
All specimens were embedded in paraffin. The transverse sections of sample A (5 µm thick) were stained with haematoxylin and eosin dyes. Ultra thin sections of sample B and C (70 to 80 nm thick) were double-stained with uranyl acetate and lead citrate and examined under a Hitachi H-7500 electron microscope at 80 kV. The histological abnormalities were quantified. The grade of distribution score (D-score) of the lesion was classified into four scores (0=no lesion, 1=lesion limited to the posterior root, 2=lesion observed both in the posterior root and posterior white matter, 3=lesion beyond the posterior root and posterior white matter). The severity score (S-score) of the lesion was classified into three scores (0=mild, 1=moderate, 2=severe). D-score plus S-score was the total nerve injury score 19 .
TUNEL staining for apoptosis
Fluorescent terminal deoxynucleotide transferasemediated dUTP nick-end labelling (TUNEL) was performed on 5 µm-thick transverse sections of sample A. Terminal deoxynucleotidyl transferase binds to exposed 3'-oH ends of DNA fragments generated in response to apoptotic signals and catalyses the addition of fluorescein-labelled deoxynucleotides.
When excited, fluorescein generates an intense signal that can be detected by fluorescence microscopy. This method allows for detection of apoptosis at the individual cell level. Apoptosis morphology is easily recognised and detected under the microscope. We used fluorescence microscopy and a 40× oil lens (Leica Dmi 4000B microscopy equipped with Leica Qwin Plus camera). Five fields under 40× lenses within one section were randomly chosen for quantification of TUNEL positive cells. For the detection of apoptosis, we used a Fluorescein FragEL™ DNA fragmentation detection kit QIA39 (Calbiochem, Darmstadt, Germany) to identify apoptotic nuclei in paraffin-embedded tissue sections. A blinded researcher counted all TUNEL-positive cells in these five fields and then expressed the data as an average count per field for each animal.
Statistical analysis
Results of %MPE and TUNEL-positive cells were expressed as mean ± SD. The data were analysed using the Student's t-test and one-way analysis of variance. Motor function scores are presented as median (10th to 90th percentiles). Motor function scores and injury scores were compared using the Kruskal-Wallis test followed by the Mann-Whitney U-test. The statistical package was SPSS software, version 13.0. A P value <0.05 was considered statistically significant.
RESULTS
Five rats were excluded from the study because of hind-limb palsy caused by traumatic catheterisation. A total of 30 rats were randomly divided into five groups: a control group (saline, n=6) and four ropivacaine groups (0.25% n=6, 0.5% n=6, 0.75% n=6 and 1.0% n=6). The pH and osmolarity of each solution are listed in Table 1 . The mean doses of ropivacaine in different groups are list in Table 2 .
Neurological function analysis Paw stimulation test
In our model, paw withdrawal thresholds were measured to evaluate the effects of intrathecal ropivacaine and were expressed as %MPE ( Figure  1 ). Across all concentrations of ropivacaine there was no dose-dependent antinociceptive inhibition of heat and mechanical stimulation. %MPE values were not significantly different from the control group. The data indicated that the sensory processing in the spinal cord and peripheral nerves did not alter after repeatedly intrathecal administration of ropivacaine.
Motor function evaluation
The duration and extent of motor block after intrathecal ropivacaine were evaluated using motor function scores. Rats in the control group could ambulate normally and had motor function scores of 0 (no block). The rats receiving the different concentrations of ropivacaine recovered fully and could ambulate within 60 minutes. The duration of block increased as the dose of ropivacaine increased. Rats treated with 1.0% ropivacaine showed higher motor function scores (more dense motor block) than 0.75% ropivacaine at 40 minutes after injection (P=0.015). Ropivacaine 0.75% resulted in higher motor function scores than 0.25% ropivacaine at 20 and 30 minutes after injection (P=0.002 and P=0.015).
Neurotoxicity assessment
Histological abnormalities were observed only in the 0.75% and 1.0% ropivacaine groups. The histological changes were mainly observed in posterior roots and the adjacent posterior white matter. The histological abnormality was defined as a lesion with infiltration of inflammatory cells, vacuolation of myelin sheaths and axons and abnormal morphology of neurons.
Electron microscopic examination showed widespread degeneration of both myelin sheaths and axons in the posterior root and abnormal neurons in the posterior spinal cord in rats treated with 1.0% ropivacaine (Figure 2 ). Electron microscopy further confirmed these histological abnormalities. There was a dose-dependent neuronal injury after repeated intrathecal administration of ropivacaine. Figure 3 , the nerve injury scores (a combination of severity and distribution of abnormality) in the rats treated with 0.75% and 1% ropivacaine were higher than those of rats treated with saline (P <0.05)
As shown in

TUNEL staining and quantification of apoptosis
To determine whether apoptosis is involved in neurotoxicity caused by exposure to ropivacaine, we examined whether exposure to ropivacaine can trigger apoptosis, as demonstrated by DNA fragmentation or cell disruption. Apoptotic cells in the spinal cord sections of animals treated with saline and 0.25% ropivacaine were rare. In ropivacaine treated groups, there were TUNEL-positive cells in both the grey and white matter, but staining was more intense within the posterior root and the posterior white matter (Figure 4) . The mean number of TUNEL-positive cells in the 0.75% and 1.0% FiguRe 3 : Nerve injury scores after an intermitted infusion of saline, 0.25% ropivacaine, 0.5% ropivacaine, 0.75% ropivacaine and 1.0% ropivacaine for 48 hours. The shaded boxes represent the 25th to 75th percentiles, and the solid line represents the median. Error bars above and below the box mark the 10th and 90th percentiles. N=six in each group. *P <0.05 compared with saline. Nerve injury score was calculated as the sum of D-score and S-score. R=ropivacaine.
table 3 Motor function evaluation after intrathecal ropivacaine
Groups
Number of rats 0 min 10 min 20 min 30 min 40 min 50 min 60 min Saline 6 0 (0,0) 0 (0,0) 0 (0,0) 0 (0,0) 0( 0,0) 0 (0,0) 0 (0,0) 0.25% R 6 0 (0,0) 4 (3,4) 0 (0,1) 0 (0,0) 0 (0,0) 0 (0,0) 0 (0,0) 0.5% R 6 0 (0,0) 4 (4,4) 2 (2,3)* 1 (0,1) 0 (0,0) 0 (0,0) 0 (0,0) 0.75% R 6 0 (0,0) 4 (4,4) 3 (2,4)* 1.5 (0,2)* 0 (0,0) 0 (0,0) 0 (0,0) 1.0% R 6 0 (0,0) 4 (4,4) 4 (3,4)*# 2 (2,3)*# 1 (0,2)*#+ 0 (0,1) 0 (0,0)
R=ropivacaine. Motor function scores are median (10th and 90th percentiles). The grading of motor block was: 0=no block, 1=partially blocked and 2=completely blocked. The normal baseline score was 0 and the score for bilateral complete block was 2+2=4. *P <0.05 vs 0.25% ropivacaine. # P <0.05 vs 0.5% ropivacaine. +P <0.05 vs 0.75% ropivacaine.
ropivacaine groups was significantly higher than saline group (P=0.000 and P=0.000) ( Figure 5) , with dose-dependent apoptotic effects.
DISCUSSIoN
The main findings of our study were: Repeated intrathecal administration of 1.
ropivacaine for 48 hours induced dose-dependent neurotoxicity. These lesions were characterised by infiltration of inflammatory cells, vacuolation of myelin sheaths and axons and abnormal morphology of neurons. Ropivacaine induced neurotoxicity was 2.
concentration-and time-dependent and, more importantly, it appeared that neurotoxicity might occur at concentrations that have been measured in the cerebrospinal fluid after spinal anaesthesia.
The mechanism of this neurotoxicity is related 3.
to, at least in part, apoptosis detected by TUNEL staining and imaging. Ropivacaine is available for spinal or intrathecal use, although data on neurotoxicity after spinal injection are not available in humans. Previous studies have demonstrated that ropivacaine has the potential to induce neurotoxicity in animal models and neuronal or non-neuronal cells. Radwan observed that all local anaesthetics produced growth cone collapse and neurite degeneration in isolated dorsal root ganglion neurons from chick embryos: the IC50 was approximately 10 -2.5 M for ropivacaine for 15 minutes of exposure 6 . Yamashita suggested that 2% ropivacaine has the lowest neurotoxicity profile among the local anaesthetics tested 2 . However, Malinovsky observed that ropivacaine did not induce any neurotoxicological lesions in rabbits with indwelling intrathecal lumbar catheters 20 . In our previous study, we found that after a six-hour exposure during continuous spinal anaesthesia, ropivacaine could induce mild neuronal injury to the spinal cord and nerve roots 16 .
In our current experiment, we used a rat model of repeated intrathecal administration of ropivacaine for 48 hours and examined the dose-and timedependent effects on neurons. The regimen of intermittent drug injection, with a dosing interval of 1.5 hours, was based on the study by Rose and colleagues. They found that the elimination halflife of intrathecal ropivacaine 20 mg in sheep was 90±36.5 minutes 21 . Many neurotoxicity studies have been conducted under different conditions, with exposure times ranging from 10 minutes to 24 hours. We evaluated the effects of 48-hour exposure at serial concentrations of ropivacaine. We hypothesised that the neurotoxicity of ropivacaine was concentrationand time-dependent. In addition, in order to study the neurotoxicity of ropivacaine in the spinal cord and not in the cauda equina, we threaded the catheter 8 cm caudally to the level of L3.
Although neurological complications have been observed with different local anaesthetics, lignocaine causes the highest incidence of transient neurological symptoms and possibly, cauda equina syndrome. our experiments suggest that histological changes within the spinal cord after 48 hours exposure to ropivacaine are similar to those from lignocaine, the neuronal injury being mainly in the posterior roots and posterior white matter. The characteristics of ropivacaine-induced damage were infiltration of inflammatory cells, degeneration of myelin sheaths and axons and apoptotic changes of neurons. These features are also observed after lignocaine 19 and the similarities may be explained by the similarity of their chemical structure.
We also observed that rats receiving 0.75% and 1% ropivacaine showed no significant alterations in sensory and motor functions after recovery from block, despite the existence of morphologic changes and neuronal apoptosis in the posterior root and posterior spinal cord. The concentration required for the inhibition of ion channel activity and excitation conduction in spinal cord neurons and peripheral nerves is much lower than the clinical concentrations we used. The higher concentration of local anaesthetic could be sufficient to cause local anaesthetic-induced neurotoxicity. our data suggested that cytotoxic-induced neuronal injury might have different mechanisms and targets other than ion channels. These targets could be mitochondrial functions, oxygen consumption and programmed cell death. Factors other than the neurotoxicity of local anaesthetics, such as pH and osmolarity, might also have affected the histological changes in our animal model. We found a few inflammatory cells along the course of catheter both in the saline control and ropivacaine groups, as did Gordh 22 and Svensson 23 .
After 0.75% and 1.0% ropivacaine administration there was induced apoptosis in the same area as the histological injury. This result differed from that of Boselli et al, who suggested that lignocaine, but not ropivacaine, can induce apoptosis on cultured T-cells in a time-dependent manner in vitro 24 . Explanations for the different findings include the different model in vitro versus in vivo, different doses of ropivacaine and different exposure times. our data suggested that local anaesthetic-induced apoptosis may play an important role in neurotoxicity.
In summary, ropivacaine can induce neurotoxicity and trigger apoptosis in a dose-dependent manner in a rat model. our data suggest that apoptosis might be a component of the neurotoxicity of ropivacaine.
